Pharmabiz2h
Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial
Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial: Columbus, Ohio Saturday, October 19, 2 ...
Pharmabiz3h
Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases
Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases: Cambridge, Massachusetts Saturday, October 1 ...
Pharmabiz4h
Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries
Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries: Winnipeg, Manitoba Saturday, October 19, 2024, 16:00 H ...
Pharmabiz5h
TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics
TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics: Tampa, Florida Saturday, October 19, 2024, 15:00 Hrs [IST] TuHURA Biosciences, a phase 3 r ...
Pharmabiz6h
Univercells Technologies by Donaldson introduces scale-X nexo bioreactor for efficient cell culture process development across multiple modalities
Univercells Technologies by Donaldson introduces scale-X nexo bioreactor for efficient cell culture process development across multiple modalities: Nivelles, Belgium Saturday, Oct ...
Pharmabiz5h
Gland Pharma appoints Shyamakant Giri as new CEO
Gland Pharma’s board has approved the appointment of Shyamakant Giri as the new chief executive officer (CEO) of the company. Giri is to join the company with effect from January 15, 2025. Giri is a ...
Pharmabiz7h
UK government to fund research into wearable technology, virtual reality and AI to support to cut drug deaths
UK government to fund research into wearable technology, virtual reality and AI to support to cut drug deaths: United Kingdom Saturday, October 19, 2024, 13:00 Hrs [IST] The UK go ...
Pharmabiz7h
Krishna Eye Centre unveils Contoura Vision Laser machine to comprehensively treat all eye related problems under one roof
Our Bureau, Mumbai Saturday, October 19, 2024, 12:30 Hrs [IST] ...
Pharmabiz12h
India needs multi-sectoral effort through govt to monitor elevated blood lead levels in young children: LM Singh
Nandita Vijayasimha, Bengaluru Saturday, October 19, 2024, 08:00 Hrs [IST] ...
Pharmabiz12h
Gujarat FDCA rolls out training for 150 officers on Revised Schedule M Guidelines
Gujarat FDCA rolls out training for 150 officers on Revised Schedule M Guidelines: Shardul Nautiyal, Mumbai Saturday, October ...
Pharmabiz10h
Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024
Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024: Rahway, New Jersey Saturday, October ...
Pharmabiz12h
CARI advances studies on metabolic disorders via traditional and modern methodologies
CARI advances studies on metabolic disorders via traditional and modern methodologies: Nandita Vijayasimha, Bengaluru Saturday, October 19, 2024, 08:00 Hrs [IST] The Central Ayurv ...